药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Perhexiline
Galcanezumab
Estrone sulfate may increase the thrombogenic activities of Galcanezumab.
Perhexiline
Fremanezumab
Estrone sulfate may increase the thrombogenic activities of Fremanezumab.
Perhexiline
Eptinezumab
Estrone sulfate may increase the thrombogenic activities of Eptinezumab.
Perhexiline
Erenumab
Estrone sulfate may increase the thrombogenic activities of Erenumab.
Perhexiline
Burosumab
Estrone sulfate may increase the thrombogenic activities of Burosumab.
Perhexiline
Tildrakizumab
Estrone sulfate may increase the thrombogenic activities of Tildrakizumab.
Perhexiline
Besilesomab
Estrone sulfate may increase the thrombogenic activities of Besilesomab.
Perhexiline
Sulesomab
Estrone sulfate may increase the thrombogenic activities of Sulesomab.
Perhexiline
Emicizumab
Estrone sulfate may increase the thrombogenic activities of Emicizumab.
Perhexiline
Human cytomegalovirus immune globulin
Estrone sulfate may increase the thrombogenic activities of Human cytomegalovirus immune globulin.
Perhexiline
Nebacumab
Estrone sulfate may increase the thrombogenic activities of Nebacumab.
Perhexiline
Edrecolomab
Estrone sulfate may increase the thrombogenic activities of Edrecolomab.
Perhexiline
Bezlotoxumab
Estrone sulfate may increase the thrombogenic activities of Bezlotoxumab.
Perhexiline
Olokizumab
Estrone sulfate may increase the thrombogenic activities of Olokizumab.
Perhexiline
Tregalizumab
Estrone sulfate may increase the thrombogenic activities of Tregalizumab.
Perhexiline
Racotumomab
Estrone sulfate may increase the thrombogenic activities of Racotumomab.
Perhexiline
Namilumab
Estrone sulfate may increase the thrombogenic activities of Namilumab.
Perhexiline
Rovalpituzumab Tesirine
Estrone sulfate may increase the thrombogenic activities of Rovalpituzumab Tesirine.
Perhexiline
Robatumumab
Estrone sulfate may increase the thrombogenic activities of Robatumumab.
Perhexiline
Milatuzumab
Estrone sulfate may increase the thrombogenic activities of Milatuzumab.